Hims & Hers Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.3B | $1.5B | $872.0M | $526.9M | $271.9M |
| Cost of revenue | $614.3M | $303.4M | $157.1M | $118.2M | $67.4M |
| Gross profit | $1.7B | $1.2B | $714.9M | $408.7M | $204.5M |
| Selling, general & administrative | — | — | — | — | $183.6M |
| Operating expenses | $1.6B | $1.1B | $744.4M | $477.4M | $319.5M |
| Operating income | $105.6M | $61.9M | -$29.5M | -$68.7M | -$115.0M |
| Interest expense | — | — | — | — | $0 |
| Pretax income | $123.9M | $71.7M | -$21.6M | -$65.7M | -$110.8M |
| Income tax expense | -$4.4M | -$54.3M | $2.0M | -$31,000 | -$3.1M |
| Net income | $128.4M | $126.0M | -$23.5M | -$65.7M | -$107.7M |
| Balance Sheet | |||||
| Cash and equivalents | $228.6M | $220.6M | $96.7M | $46.8M | $71.8M |
| Current assets | $767.6M | $395.8M | $265.1M | $216.6M | $269.9M |
| Total assets | $2.2B | $707.5M | $441.2M | $366.3M | $420.6M |
| Current liabilities | $404.4M | $221.4M | $88.5M | $47.9M | $79.2M |
| Total liabilities | $1.6B | $230.8M | $97.2M | $54.6M | $86.0M |
| Stockholders' equity | $540.9M | $476.7M | $344.0M | $311.7M | $334.6M |
| Cash Flow Statement | |||||
| Cash from operations | $300.0M | $251.1M | $73.5M | -$26.5M | -$34.4M |
| Depreciation and amortization | $54.5M | $17.1M | $9.5M | $7.5M | $4.1M |
| Stock-based compensation | $135.2M | $92.3M | $66.1M | $42.8M | $67.2M |
| Capital expenditure | $242.6M | $52.8M | $26.5M | $7.2M | $0 |
| Free cash flow | $57.4M | $198.3M | $47.0M | -$33.7M | -$34.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | $90.0M | $83.0M | $2.0M | $0 | $0 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 231.5M · Free float 71.6%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.